Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 17 2 2022
medline: 9 4 2022
entrez: 16 2 2022
Statut: ppublish

Résumé

Background In addition to primary neurodegenerative processes, vascular disorders, such as stroke, can lead to parkinsonism. However, some cardiovascular risk factors, such as smoking and elevated cholesterol levels, are associated with reduced risk of Parkinson disease. We examined the risk of Parkinson disease and secondary parkinsonism in 1-year survivors of myocardial infarction (MI). Methods and Results We conducted a nationwide population-based matched cohort study using Danish medical registries from 1995 to 2016. We identified all patients with a first-time MI diagnosis and sampled a sex-, age-, and calendar year-matched general population comparison cohort without MI. Cox regression analysis was used to compute adjusted hazard ratios (aHRs) for Parkinson disease and secondary parkinsonism, controlled for matching factors and adjusted for relevant comorbidities and socioeconomic factors. We identified 181 994 patients with MI and 909 970 matched comparison cohort members (median age, 71 years; 62% men). After 21 years of follow-up, the cumulative incidence was 0.9% for Parkinson disease and 0.1% for secondary parkinsonism in the MI cohort. Compared with the general population cohort, MI was associated with a decreased risk of Parkinson disease (aHR, 0.80; 95% CI, 0.73-0.87) and secondary parkinsonism (aHR, 0.72; 95% CI, 0.54-0.94). Conclusions MI was associated with a 20% decreased risk of Parkinson disease and 28% decreased risk of secondary parkinsonism. Reduced risk may reflect an inverse relationship between cardiovascular risk factors and Parkinson disease.

Identifiants

pubmed: 35170978
doi: 10.1161/JAHA.121.022768
pmc: PMC9075091
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e022768

Subventions

Organisme : NIA NIH HHS
ID : P30 AG066515
Pays : United States

Références

Scand J Public Health. 2011 Jul;39(7 Suppl):95-8
pubmed: 21775363
Neurology. 2006 Dec 12;67(11):1955-9
pubmed: 17159100
Circulation. 2020 Apr 7;141(14):1205-1207
pubmed: 32250706
Circulation. 2018 Feb 6;137(6):567-577
pubmed: 29025764
Ageing Res Rev. 2014 Nov;18:41-52
pubmed: 25107566
Clin Epidemiol. 2018 Sep 25;10:1325-1337
pubmed: 30310326
Clin Epidemiol. 2019 Jul 12;11:563-591
pubmed: 31372058
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Mov Disord. 2010 Feb 15;25(3):341-8
pubmed: 20108376
Am J Epidemiol. 2006 Nov 15;164(10):998-1002
pubmed: 16905642
Stroke. 2006 May;37(5):1184-8
pubmed: 16574924
BMJ. 1998 Apr 4;316(7137):1043-7
pubmed: 9552903
Stroke. 2016 Jul;47(7):1727-33
pubmed: 27301935
Eur J Neurol. 2008 Sep;15(9):965-8
pubmed: 18637822
Neurology. 2008 Feb 19;70(8):e32-4
pubmed: 18285529
BMJ. 2012 Jan 25;344:e356
pubmed: 22279115
J Clin Neurol. 2012 Mar;8(1):15-21
pubmed: 22523509
Br J Psychiatry. 2017 May;210(5):356-361
pubmed: 28254961
Eur J Clin Nutr. 2015 Jun;69(6):729-33
pubmed: 25514902
Hypertension. 2011 Jun;57(6):1094-100
pubmed: 21536985
Lancet Neurol. 2005 Dec;4(12):866-76
pubmed: 16297844
Mov Disord. 2018 Aug;33(8):1298-1305
pubmed: 30145829
Mov Disord. 2020 Jan;35(1):55-74
pubmed: 31483535
BMC Med Res Methodol. 2011 May 28;11:83
pubmed: 21619668
Eur J Prev Cardiol. 2015 Feb;22(2):189-95
pubmed: 24165474
Clin Epidemiol. 2018 Sep 04;10:1147-1154
pubmed: 30233249
Ann Neurol. 2001 Dec;50(6):780-6
pubmed: 11761476
Neurology. 2018 Apr 17;90(16):e1413-e1417
pubmed: 29661903
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
BMJ Open. 2013 Jun 20;3(6):
pubmed: 23794587
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Medicine (Baltimore). 2016 Jul;95(30):e4337
pubmed: 27472716
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Arch Neurol. 2007 Jul;64(7):990-7
pubmed: 17620489
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Ann Intern Med. 2017 Aug 15;167(4):268-274
pubmed: 28693043
Nat Rev Neurol. 2015 Jun;11(6):319-26
pubmed: 25917706
Stroke. 2012 Oct;43(10):2574-9
pubmed: 22858727
J Am Heart Assoc. 2016 Sep 07;5(9):
pubmed: 27604456
Dan Med Bull. 1997 Sep;44(4):445-8
pubmed: 9377907
BMJ. 2008 Dec 15;337:a2494
pubmed: 19074944
BMJ Open. 2016 Nov 18;6(11):e012832
pubmed: 27864249

Auteurs

Jens Sundbøll (J)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.
Department of Cardiology Aarhus University Hospital Aarhus Denmark.

Szimonetta Komjáthiné Szépligeti (SK)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.

Péter Szentkúti (P)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.

Kasper Adelborg (K)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.

Erzsébet Horváth-Puhó (E)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.

Lars Pedersen (L)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.

Victor W Henderson (VW)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.
Departments of Epidemiology and Population Health Stanford University Stanford CA.
Departments of Neurology and Neurological Sciences Stanford University Stanford CA.

Henrik Toft Sørensen (HT)

Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark.
Departments of Epidemiology and Population Health Stanford University Stanford CA.
Departments of Neurology and Neurological Sciences Stanford University Stanford CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH